Motivation: The probability of effective treatment of cancer with a targeted therapeutic can be im-proved for patients with defined genotypes containing actionable mutations. To this end, many human cancer biobanks are integrating more tightly with genomic sequencing facilities and with those creating and maintaining patient-derived xenografts (PDX) and cell lines to provide renew-able resources for translational research. Results: To support the complex data management needs and workflows of several such biobanks, we developed Acquire. It is a robust, secure, web-based, database-backed open-source system that supports all major needs of a modern cancer biobank. Its modules allow for i) up-to-the-minute ‘scoreboard ’ and graphical reporting...
The progress in translational cancer research relies on access to well-characterized samples from a ...
Biobanks include biological samples and attached databases. Human biobanks occur in research, techno...
The first biobank in Russia was created in 1998 to investigate post-Chernobyl thyroid tumors. The nu...
Motivation: The probability of effective treatment of cancer with a targeted therapeutic can be impr...
Translational cancer research is highly dependent of large series of cases including high quality sa...
biospecimens with appropriate clinical annotation are critical to advancing basic and translational ...
Background: Today's translational cancer research increasingly depends on international multi-center...
According to the National Cancer Institute, the lack of standardized, high-quality biospecimens is o...
Tumorbank@UZA is an academic hospital integrated biobank that collects tissue, blood and urine sampl...
BACKGROUND: Biobanks play a critical role in cancer research by providing high quality biological sa...
Cancer is one of the four major non-communicable diseases (NCD), responsible for similar to 14.6% of...
Biorespositories of formalin-fixed and paraffin-embedded (FFPE) or fresh frozen human tissues from m...
The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-cli...
AbstractThe National Cancer Institute (NCI) Cancer Biomedical Informatics Grid® (caBIG®) program est...
Tumor biobanks are critical components of the biomedical research infrastructure. Biospeci-mens coll...
The progress in translational cancer research relies on access to well-characterized samples from a ...
Biobanks include biological samples and attached databases. Human biobanks occur in research, techno...
The first biobank in Russia was created in 1998 to investigate post-Chernobyl thyroid tumors. The nu...
Motivation: The probability of effective treatment of cancer with a targeted therapeutic can be impr...
Translational cancer research is highly dependent of large series of cases including high quality sa...
biospecimens with appropriate clinical annotation are critical to advancing basic and translational ...
Background: Today's translational cancer research increasingly depends on international multi-center...
According to the National Cancer Institute, the lack of standardized, high-quality biospecimens is o...
Tumorbank@UZA is an academic hospital integrated biobank that collects tissue, blood and urine sampl...
BACKGROUND: Biobanks play a critical role in cancer research by providing high quality biological sa...
Cancer is one of the four major non-communicable diseases (NCD), responsible for similar to 14.6% of...
Biorespositories of formalin-fixed and paraffin-embedded (FFPE) or fresh frozen human tissues from m...
The inter- and intra-tumor heterogeneity of breast cancer needs to be adequately captured in pre-cli...
AbstractThe National Cancer Institute (NCI) Cancer Biomedical Informatics Grid® (caBIG®) program est...
Tumor biobanks are critical components of the biomedical research infrastructure. Biospeci-mens coll...
The progress in translational cancer research relies on access to well-characterized samples from a ...
Biobanks include biological samples and attached databases. Human biobanks occur in research, techno...
The first biobank in Russia was created in 1998 to investigate post-Chernobyl thyroid tumors. The nu...